How Healthcare and Pharma Companies Can Build Business Resilience

Climate and Nature Risk is Business Risk for Healthcare and Pharma

Transitioning profitably towards the low-carbon economy is presenting global healthcare and pharma companies with unprecedented market challenges. We can help.

Organizations face multiple threats to the bottom line, including tariffs, geopolitical risks, disruption to supply chains, and tightening emissions regulations. Navigating the realities of climate and nature related risks requires a data-driven approach to ensure long-term profitability and resilience.

How We Help

In an era of economic, geo-political and environmental uncertainty global healthcare and pharma companies face unprecedented market challenges. The Risilience-powered platform, Riise, and team of specialists support global healthcare and pharma companies to quantify, strategize, and deliver on the financial impacts of climate and nature risks and opportunities, building business resilience and growth.

How Risilience Supports Healthcare and Pharma

RISILIENCE PHARMA FLYER

Don’t Just Take Our Word for It

reckitt logo

Risilience is grounded on fundamentally great research. When I talk to stakeholders for Reckitt, having the backup of Risilience behind us as we talk about climate change risk is really important and powerful. The Risilience solution has been instrumental in communicating with investors, shareholders, board, policy makers, customers and other internal and external stakeholder groups. If you haven’t got the right technology, you create risk for yourself and we see this through the work we do with Risilience.

Global Director Sustainability, Environment and Human Rights

Reckitt

Ready to Learn More?

contact

Book a Demo

At Risilience, our mission is to help global organizations to build strategic resilience and grow business value in the era of climate disruption and economic uncertainty.

Book a demo of the award-winning Riise platform with one of our expert consultants.